Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 120-127, June 2007

Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers

  • Hrushikesh B. Agashe, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
    • Corresponding Author InformationCorresponding author. Hrushikesh B. Agashe, Institute of Nuclear Medicine and Allied Sciences, Brig. S.K. Mazumdar Road, New Delhi 110054, India
  • ,
  • Anil Kumar Babbar, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Sanyog Jain, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Rakesh Kumar Sharma, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Anil Kumar Mishra, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Abhay Asthana, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
  • ,
  • Minakshi Garg, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
  • ,
  • Tathagata Dutta, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
  • ,
  • Narendra Kumar Jain, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India

Received 27 November 2006; accepted 5 February 2007.

Abstract 

The purpose of this work was to study the biodistribution pattern of the fifth generation of poly(propylene imine) dendrimer (PPI-5.0G)-based carbohydrate (mannose and lactose)-coated glycodendrimers in mice so as to explore the potential of these systems as drug carriers. Plain dendrimers were synthesized and coated with carbohydrates following the reported procedures. The formulations were labeled with radioactive technetium (sodium pertechnetate; 99mTcO4-) and characterized for labeling efficiency as well as in vitro and in vivo stability of the labeled complexes. The blood clearance study was performed in female New Zealand rabbits. The periodic in vivo biodistribution profile of the formulations was investigated in female Balb/c mice. The dendrimeric formulations were labeled with 95% labeling efficiency. The labeled complexes were found to be stable in vitro (97% to 98% stability) and in vivo (89% to 94% stability). All the formulations were cleared rapidly from circulation; clearance of mannose-coated poly (propylene imine) dendrimer (M-PPI) and lactose-coated poly(propylene imine) dendrimer (L-PPI) was faster than PPI-5.0G. All the formulations accumulated in liver to a significant extent, but only those with terminal carbohydrate moieties were retained for a longer period. Significant accumulation of PPI-5.0G and M-PPI was observed in kidneys as against very less activity in the case of L-PPI. Rapid clearance of the dendrimers was in accordance with the earlier reports. Higher and prolonged retention of M-PPI and L-PPI in liver was attributed to lectin-carbohydrate interactions. Lesser accumulation of L-PPI in kidneys was suggestive of its lesser excretion. This observation can be explained on the basis of the molecular weight of L-PPI, which was greater than the threshold of glomerular excretion. In general, it was observed that the carbohydrate-coated dendrimers were distributed in liver to a significant extent. This information could serve as a useful platform in designing carbohydrate-coated dendrimers for selective delivery of bioactive agents to liver.

Key words: Poly(propylene imine) dendrimers, Glycodendrimers, Technetium-99m, Biodistribution

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00048-2

doi:10.1016/j.nano.2007.02.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 120-127, June 2007